Kathryn Lang

618 total citations · 1 hit paper
24 papers, 399 citations indexed

About

Kathryn Lang is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Kathryn Lang has authored 24 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Cancer Research and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Kathryn Lang's work include Cancer Genomics and Diagnostics (6 papers), Colorectal Cancer Treatments and Studies (4 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Kathryn Lang is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Colorectal Cancer Treatments and Studies (4 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Kathryn Lang collaborates with scholars based in United States, United Kingdom and Spain. Kathryn Lang's co-authors include Elisheva Coleman, Rohitha Moudgal, Oluwole O. Awosika, Wuwei Feng, Brett Kissela, Hyacinth I. Hyacinth, Jason C. K. Chan, Surjit Lidder, Victoria M. Raymond and Junhua Yu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Kathryn Lang

23 papers receiving 389 citations

Hit Papers

Early Rehabilitation After Stroke: a Narrative Review 2017 2026 2020 2023 2017 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathryn Lang United States 9 163 82 71 65 48 24 399
Hyacinth I. Hyacinth United States 10 165 1.0× 103 1.3× 108 1.5× 43 0.7× 88 1.8× 29 506
Kamil Chwojnicki Poland 12 71 0.4× 143 1.7× 32 0.5× 25 0.4× 52 1.1× 36 422
Min‐Keun Song South Korea 12 96 0.6× 63 0.8× 64 0.9× 27 0.4× 39 0.8× 77 421
Caila B. Vaughn United States 14 26 0.2× 92 1.1× 48 0.7× 34 0.5× 112 2.3× 34 621
Ilaria Maestrini Italy 12 147 0.9× 304 3.7× 147 2.1× 19 0.3× 160 3.3× 22 610
Benedikt Frank Germany 13 63 0.4× 267 3.3× 108 1.5× 51 0.8× 239 5.0× 65 625
Sharmila Sagnier France 12 142 0.9× 243 3.0× 116 1.6× 67 1.0× 90 1.9× 36 495
Paweł Sokal Poland 14 44 0.3× 119 1.5× 107 1.5× 46 0.7× 175 3.6× 49 554
Jeffrey Minuk Canada 13 91 0.6× 196 2.4× 193 2.7× 47 0.7× 110 2.3× 20 585

Countries citing papers authored by Kathryn Lang

Since Specialization
Citations

This map shows the geographic impact of Kathryn Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Lang more than expected).

Fields of papers citing papers by Kathryn Lang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Lang. The network helps show where Kathryn Lang may publish in the future.

Co-authorship network of co-authors of Kathryn Lang

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Lang. A scholar is included among the top collaborators of Kathryn Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Lang. Kathryn Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Strickler, John H., Ling‐I Hsu, Phoebe Wright, et al.. (2023). Real-World Treatment Patterns in Patients With HER2-Amplified Metastatic Colorectal Cancer: A Clinical-Genomic Database Study. Journal of the National Comprehensive Cancer Network. 21(8). 805–812.e1. 5 indexed citations
2.
Lang, Kathryn, et al.. (2023). A new approach to building a strong leadership bench. Nursing Management. 54(3). 8–12.
3.
Raymond, Victoria M., et al.. (2022). Screening for high frequency malignant disease (SHIELD).. Journal of Clinical Oncology. 40(16_suppl). TPS1602–TPS1602. 2 indexed citations
4.
Hanna, David B., Junhua Yu, Aaron Hardin, et al.. (2021). Abstract PS18-15: Real-world clinical-genomic data identifies the ESR1 clonal and subclonal circulating tumor DNA (ctDNA) landscape and provides insight into clinical outcomes. Cancer Research. 81(4_Supplement). PS18–15. 2 indexed citations
5.
Heist, Rebecca S., Junhua Yu, Nicole Zhang, et al.. (2021). Impact of STK11 mutation on first-line immune checkpoint inhibitor (ICI) outcomes in a real-world KRAS G12C mutant lung adenocarcinoma cohort.. Journal of Clinical Oncology. 39(15_suppl). 9106–9106. 5 indexed citations
6.
Raymond, Victoria M., et al.. (2021). Evaluation of the ctDNA LUNAR-2 Test In an Average Patient Screening Episode (ECLIPSE).. Journal of Clinical Oncology. 39(3_suppl). TPS142–TPS142. 13 indexed citations
7.
Rich, Thereasa A., Victoria M. Raymond, & Kathryn Lang. (2020). Mo1617 WHERE ARE WE TODAY? EFFORTS TO UNDERSTAND STRATEGIES AND BARRIERS TO PHYSICIAN ISSUANCE OF A RECOMMENDATION FOR COLORECTAL CANCER SCREENING: A SYSTEMATIC REVIEW. Gastroenterology. 158(6). S–918. 1 indexed citations
8.
Hardin, Aaron, et al.. (2020). Abstract 4421: Development of a clinical-genomic database to study tumor evolution and molecular biomarkers of drug resistance in a real-world setting. Cancer Research. 80(16_Supplement). 4421–4421. 1 indexed citations
9.
Conroy, Joseph D., et al.. (2020). Bottom hypoxia alters the spatial distribution of pelagic intermediate consumers and their prey. Canadian Journal of Fisheries and Aquatic Sciences. 78(5). 522–538. 6 indexed citations
10.
Cappelleri, Joseph C., et al.. (2018). Social preferences for health states associated with acute myeloid leukemia for patients undergoing treatment in the United Kingdom. Health and Quality of Life Outcomes. 16(1). 9 indexed citations
11.
Coleman, Elisheva, Rohitha Moudgal, Kathryn Lang, et al.. (2017). Early Rehabilitation After Stroke: a Narrative Review. Current Atherosclerosis Reports. 19(12). 59–59. 258 indexed citations breakdown →
12.
Ireland, Robin, Kathryn Lang, Aytug Kizilors, et al.. (2017). Women Administered Standard Dose Imatinib for Chronic Myeloid Leukemia Have Higher Dose-Adjusted Plasma Imatinib and Norimatinib Concentrations Than Men. Therapeutic Drug Monitoring. 39(5). 499–504. 12 indexed citations
13.
Chan, Jason C. K., et al.. (2017). Retrieval-enhanced suggestibility: A retrospective and a new investigation.. Journal of Applied Research in Memory and Cognition. 6(3). 213–229. 32 indexed citations
14.
Mabley, Jon G., et al.. (2015). Rivaroxaban-Mediated Vascular Relaxation As a Potential Cause of Headaches and Dizziness. Blood. 126(23). 2334–2334. 1 indexed citations
15.
Lang, Kathryn, Jignesh P. Patel, Julia Czuprynska, et al.. (2015). The First Registry: Follow-up in Rivaroxaban Patients in the Setting of Venous Thromboembolism. Blood. 126(23). 4737–4737. 1 indexed citations
16.
Lang, Kathryn, Prakash Saha, Lara N. Roberts, & Roopen Arya. (2015). Changing paradigms in the management of deep vein thrombosis. British Journal of Haematology. 170(2). 162–174. 8 indexed citations
17.
Lang, Kathryn & Surjit Lidder. (2010). Under-representation of the elderly in cancer clinical trials. British Journal of Hospital Medicine. 71(12). 678–681. 10 indexed citations
18.
Lidder, Surjit, et al.. (2009). Tuberculosis of the knee. Orthopedic Reviews. 1(2). e24–e24. 10 indexed citations
19.
Lang, Kathryn, et al.. (2009). Massive pleural effusion due to IgG multiple myeloma. Hematology Reports. 1(2). 18–18. 4 indexed citations
20.
Lang, Kathryn, et al.. (2009). The Value Analysis Team. The Health Care Manager. 28(2). 165–171. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026